Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 126, Issue 25
December 17 2015
Issue Cover

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
EBV and memory B cells: an affair with consequences
Rajiv Khanna
View Articletitled, EBV and memory B cells: an affair with consequences
INSIDE BLOOD COMMENTARY
Idelalisib has CLL on the run!
Clinical Trials & Observations
Jennifer R. Brown
View Articletitled, Idelalisib has CLL on the run!
INSIDE BLOOD COMMENTARY
The Rap1-RIAM pathway prefers β2 integrins
David A. Calderwood
View Articletitled, The Rap1-RIAM pathway prefers β2 integrins
INSIDE BLOOD COMMENTARY
To stimulate the phagocytes
Niels Borregaard
View Articletitled, To stimulate the phagocytes
INSIDE BLOOD COMMENTARY
TRALI: hit by CRP
Karina Yazdanbakhsh
View Articletitled, TRALI: hit by CRP
INSIDE BLOOD COMMENTARY
GVHD meets GWAS
Miguel Waterhouse
View Articletitled, GVHD meets GWAS

PLENARY PAPER

TRANSPLANTATION
Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event
David M. Burns,Rose Tierney,Claire Shannon-Lowe,Jo Croudace,Charlotte Inman,Ben Abbotts,Sandeep Nagra,Christopher P. Fox,Sridhar Chaganti,Charles F. Craddock,Paul Moss,Alan B. Rickinson,Martin Rowe,Andrew I. Bell
View Articletitled, Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event
Supplemental data

REVIEW ARTICLE

Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia
Alejandra Sanjuan-Pla,Clara Bueno,Cristina Prieto,Pamela Acha,Ronald W. Stam,Rolf Marschalek,Pablo Menéndez
View Articletitled, Revisiting the biology of infant t(4;11)/MLL-AF4<sup>+</sup> B-cell acute lymphoblastic leukemia

CLINICAL TRIALS AND OBSERVATIONS

A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
Clinical Trials & Observations
Susan M. O'Brien,Nicole Lamanna,Thomas J. Kipps,Ian Flinn,Andrew D. Zelenetz,Jan A. Burger,Michael Keating,Siddhartha Mitra,Leanne Holes,Albert S. Yu,David M. Johnson,Langdon L. Miller,Yeonhee Kim,Roger D. Dansey,Ronald L. Dubowy,Steven E. Coutre
View Articletitled, A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
Supplemental data

IMMUNOBIOLOGY

Rap1 and its effector RIAM are required for lymphocyte trafficking
Wenjuan Su,Joseph Wynne,Elaine M. Pinheiro,Marianne Strazza,Adam Mor,Emilie Montenont,Jeffrey Berger,David S. Paul,Wolfgang Bergmeier,Frank B. Gertler,Mark R. Philips
View Articletitled, Rap1 and its effector RIAM are required for lymphocyte trafficking
Supplemental data
Loss of the Rap1 effector RIAM results in leukocyte adhesion deficiency due to impaired β2 integrin function in mice
Sarah Klapproth,Markus Sperandio,Elaine M. Pinheiro,Monika Prünster,Oliver Soehnlein,Frank B. Gertler,Reinhard Fässler,Markus Moser
View Articletitled, Loss of the Rap1 effector RIAM results in leukocyte adhesion deficiency due to impaired β2 integrin function in mice
Supplemental data

LYMPHOID NEOPLASIA

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Marie-Lorraine Chretien,Jill Corre,Valerie Lauwers-Cances,Florence Magrangeas,Alice Cleynen,Edwige Yon,Cyrille Hulin,Xavier Leleu,Frederique Orsini-Piocelle,Jean-Sebastien Blade,Claudine Sohn,Lionel Karlin,Xavier Delbrel,Benjamin Hebraud,Murielle Roussel,Gerald Marit,Laurent Garderet,Mohamad Mohty,Philippe Rodon,Laurent Voillat,Bruno Royer,Arnaud Jaccard,Karim Belhadj,Jean Fontan,Denis Caillot,Anne-Marie Stoppa,Michel Attal,Thierry Facon,Philippe Moreau,Stephane Minvielle,Hervé Avet-Loiseau
View Articletitled, Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Supplemental data

MYELOID NEOPLASIA

KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy
Clinical Trials & Observations Brief Report
David T. Yeung,Carine Tang,Ljiljana Vidovic,Deborah L. White,Susan Branford,Timothy P. Hughes,Agnes S. Yong
View Articletitled, <em>KIR2DL5B</em> genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis
Juhi Bagaitkar,Nancy K. Pech,Stoyan Ivanov,Anthony Austin,Melody Yue Zeng,Sabine Pallat,Guangming Huang,Gwendalyn J. Randolph,Mary C. Dinauer
View Articletitled, NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9
Brief Report
Klaus Schmitz-Abe,Szymon J. Ciesielski,Paul J. Schmidt,Dean R. Campagna,Fedik Rahimov,Brenda A. Schilke,Marloes Cuijpers,Klaus Rieneck,Birgitte Lausen,Michael L. Linenberger,Anoop K. Sendamarai,Chaoshe Guo,Inga Hofmann,Peter E. Newburger,Dana Matthews,Akiko Shimamura,Pieter J. L. M. Snijders,Meghan C. Towne,Charlotte M. Niemeyer,Henry G. Watson,Morten H. Dziegiel,Matthew M. Heeney,Alison May,Sylvia S. Bottomley,Dorine W. Swinkels,Kyriacos Markianos,Elizabeth A. Craig,Mark D. Fleming
View Articletitled, Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue <em>HSPA9</em>
Supplemental data

THROMBOSIS AND HEMOSTASIS

Low ADAMTS13 activity is associated with an increased risk of ischemic stroke
Clinical Trials & Observations
Michelle A. H. Sonneveld,Moniek P. M. de Maat,Marileen L. P. Portegies,Maryam Kavousi,Albert Hofman,Peter L. Turecek,Hanspeter Rottensteiner,Fritz Scheiflinger,Peter J. Koudstaal,M. Arfan Ikram,Frank W. G. Leebeek
View Articletitled, Low ADAMTS13 activity is associated with an increased risk of ischemic stroke
Supplemental data

TRANSFUSION MEDICINE

C-reactive protein enhances murine antibody–mediated transfusion-related acute lung injury
Rick Kapur,Michael Kim,Shanjeevan Shanmugabhavananthan,Jonathan Liu,Yuan Li,John W. Semple
View Articletitled, C-reactive protein enhances murine antibody–mediated transfusion-related acute lung injury

TRANSPLANTATION

Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation
Clinical Trials & Observations
Aiko Sato-Otsubo,for the Japan Marrow Donor Program,Yasuhito Nannya,for the Japan Marrow Donor Program,Koichi Kashiwase,for the Japan Marrow Donor Program,Makoto Onizuka,for the Japan Marrow Donor Program,Fumihiro Azuma,for the Japan Marrow Donor Program,Yoshiki Akatsuka,for the Japan Marrow Donor Program,Yasuko Ogino,for the Japan Marrow Donor Program,Masahiro Satake,for the Japan Marrow Donor Program,Masashi Sanada,for the Japan Marrow Donor Program,Shigeru Chiba,for the Japan Marrow Donor Program,Hiroh Saji,for the Japan Marrow Donor Program,Hidetoshi Inoko,for the Japan Marrow Donor Program,Giulia C. Kennedy,for the Japan Marrow Donor Program,Ken Yamamoto,for the Japan Marrow Donor Program,Satoko Morishima,for the Japan Marrow Donor Program,Yasuo Morishima,for the Japan Marrow Donor Program,Yoshihisa Kodera,for the Japan Marrow Donor Program,Takehiko Sasazuki,for the Japan Marrow Donor Program,Seishi Ogawa,for the Japan Marrow Donor Program
View Articletitled, Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation
Supplemental data

BLOOD WORK

Pediatric blastic plasmacytoid dendritic cell neoplasm, acute leukemic variant
Huifei Liu,Shaoying Li
View Articletitled, Pediatric blastic plasmacytoid dendritic cell neoplasm, acute leukemic variant

ERRATA

Rook AH, Gelfand JC, Wysocka M, et al. Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma. Blood. 2015;126(12):1452-1461.
View Articletitled, Rook AH, Gelfand JC, Wysocka M, et al. Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma. <em>Blood</em>. 2015;126(12):1452-1461.
Lee W-C, Malleret B, Lau Y-L, et al. Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes. Blood. 2014;123(18):e100-e109.
View Articletitled, Lee W-C, Malleret B, Lau Y-L, et al. Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes. <em>Blood</em>. 2014;123(18):e100-e109.
All Issues

Advertisement intended for health care professionals

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma
High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia
Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial
Doubling down on GPRC5D in multiple myeloma

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals